Correlation Between NYSE Composite and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Blueprint Medicines Corp, you can compare the effects of market volatilities on NYSE Composite and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Blueprint Medicines.
Diversification Opportunities for NYSE Composite and Blueprint Medicines
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between NYSE and Blueprint is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of NYSE Composite i.e., NYSE Composite and Blueprint Medicines go up and down completely randomly.
Pair Corralation between NYSE Composite and Blueprint Medicines
Assuming the 90 days trading horizon NYSE Composite is expected to generate 3.99 times less return on investment than Blueprint Medicines. But when comparing it to its historical volatility, NYSE Composite is 4.79 times less risky than Blueprint Medicines. It trades about 0.24 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 8,277 in Blueprint Medicines Corp on August 28, 2024 and sell it today you would earn a total of 1,110 from holding Blueprint Medicines Corp or generate 13.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Blueprint Medicines Corp
Performance |
| Timeline |
NYSE Composite and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Blueprint Medicines Corp
Pair trading matchups for Blueprint Medicines
Pair Trading with NYSE Composite and Blueprint Medicines
The main advantage of trading using opposite NYSE Composite and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| NYSE Composite vs. Hooker Furniture | NYSE Composite vs. Hudson Pacific Properties | NYSE Composite vs. Canlan Ice Sports | NYSE Composite vs. Boston Properties |
| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |